Journal Article10.1016/S0022-5347(01)61700-2
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Anthony V. D'Amico,R. Whittington,S.B. Malkowicz,Daniel Schultz,Kenneth R. Blank,Gregory A. Broderick,John E. Tomaszewski,Andrew A. Renshaw,Irving D. Kaplan,Clair J. Beard,Alan J. Wein +10 more
TL;DR: Low-risk patients had estimates of 5-year PSA outcome after treatment with RP, RT, or implant with or without neoadjuvant androgen deprivation that were not statistically different, whereas intermediate- and high- risk patients treated with RP or RT did better then those treated by implant.
read more
About: This article is published in The Journal of Urology. The article was published on 01 Apr 1999. The article focuses on the topics: PSA Failure & Prostate cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results From the International Staging Collaboration for Cancer of the Prostate.
Robert T. Dess,Krithika Suresh,Michael J. Zelefsky,Stephen J. Freedland,Stephen J. Freedland,Brandon A. Mahal,Matthew R. Cooperberg,Brian J. Davis,Eric M. Horwitz,Martha K. Terris,Christopher L. Amling,William J. Aronson,Christopher J. Kane,William C. Jackson,Jason W.D. Hearn,Curtiland Deville,Theodore L. DeWeese,Stephen Greco,Todd McNutt,Danny Y. Song,Yilun Sun,Rohit Mehra,Samuel D. Kaffenberger,Todd M. Morgan,Paul L. Nguyen,Felix Y. Feng,Vidit Sharma,Phuoc T. Tran,Bradley J. Stish,Thomas M. Pisansky,Nicholas G. Zaorsky,Fabio Y. Moraes,Alejandro Berlin,Alejandro Berlin,Antonio Finelli,Antonio Finelli,Nicola Fossati,Giorgio Gandaglia,Alberto Briganti,Peter R. Carroll,R. Jeffrey Karnes,Michael W. Kattan,Matthew J. Schipper,Daniel E. Spratt +43 more
TL;DR: The Score system performed similarly to individualized random survival forest and interaction models and outperformed National Comprehensive Cancer Network (NCCN) and Cancer of the Prostate Risk Assessment (CAPRA) risk grouping 3- and 4-tier classification systems.
Image-guided stereotactic body radiation therapy for localized prostate cancer
Jin Kyu Kang,Chul Koo Cho,Chul Won Choi,Seong Yul Yoo,Mi Sook Kim,Kwangmo Yang,Hyung Jun Yoo,Jin Ho Kim,Young Seok Seo,Dong Han Lee,Moon Ki Jo +10 more
TL;DR: SBRT using CyberKnife for localized prostate cancer is safe and well tolerated and promising results with 34 Gy in a 4-fraction regimen especially for the high-risk patients are obtained.
The clinical effectiveness and cost-effectiveness of the PROGENSA® prostate cancer antigen 3 assay and the Prostate Health Index in the diagnosis of prostate cancer: a systematic review and economic evaluation
Amanda Nicholson,James Mahon,Angela Boland,Sophie Beale,Kerry Dwan,Nigel Fleeman,Juliet Hockenhull,Yenal Dundar +7 more
TL;DR: Evaluating the clinical effectiveness and cost-effectiveness of the PCA3 assay and the phi in the diagnosis of prostate cancer indicated that the use of these tests in the NHS would not be cost-effective.
74
Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines
Neal D. Shore,Emmanuel S. Antonarakis,Michael S. Cookson,E. David Crawford,Alicia K. Morgans,David M. Albala,Jason Hafron,Jason Hafron,Richard G. Harris,Daniel Saltzstein,Gordon A. Brown,Jonathan Henderson,Benjamin H Lowentritt,Jeffrey M. Spier,Raoul S. Concepcion,Raoul S. Concepcion +15 more
TL;DR: The risk‐benefit analysis for initiating ADT in PC patients throughout the PC disease continuum warrants review.
74
Detection of prostate cancer index lesions with multiparametric magnetic resonance imaging (mp-MRI) using whole-mount histological sections as the reference standard
Filippo Russo,Daniele Regge,Enrico Armando,Valentina Giannini,Anna Vignati,Simone Mazzetti,Matteo Manfredi,Enrico Bollito,Loredana Correale,Francesco Porpiglia +9 more
TL;DR: To evaluate the sensitivity of multiparametric magnetic resonance imaging (mp‐MRI) for detecting prostate cancer foci, including the largest (index) lesions, the largest lesions are examined.
74
References
Nonparametric Estimation from Incomplete Observations
Edward L. Kaplan,Paul Meier +1 more
TL;DR: In this article, the product-limit (PL) estimator was proposed to estimate the proportion of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t).
Regression Models and Life-Tables
TL;DR: The analysis of censored failure times is considered in this paper, where the hazard function is taken to be a function of the explanatory variables and unknown regression coefficients multiplied by an arbitrary and unknown function of time.
28.6K
Results of Conservative Management of Clinically Localized Prostate Cancer
Gerald W. Chodak,Ronald A. Thisted,Glenn S. Gerber,Jan-Erik Johansson,Jan Adolfsson,George W. Jones,Geoff D. Chisholm,Boaz Moskovitz,Pinhas M. Livne,John J. Warner +9 more
TL;DR: The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.
913
Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma
TL;DR: There is a high rate of clinical and chemical freedom from progression following 125I implantation for select patients with early stage prostatic carcinoma.
274
Related Papers (5)
Nicolas Mottet,Joaquim Bellmunt,Michel Bolla,Erik Briers,Marcus G. Cumberbatch,Maria De Santis,Nicola Fossati,Tobias Gross,Ann Henry,Steven Joniau,Thomas B. Lam,Thomas B. Lam,Malcolm David Mason,Vsevolod Matveev,Paul C. Moldovan,Roderick C.N. van den Bergh,Thomas Van den Broeck,Henk G. van der Poel,Theo H. van der Kwast,Olivier Rouvière,Ivo G. Schoots,Thomas Wiegel,Philip Cornford +22 more
Geert J.L.H. van Leenders,Theodorus van der Kwast,David J. Grignon,Andrew Evans,Glen Kristiansen,Charlotte F. Kweldam,Geert Litjens,Jesse K. McKenney,Jonathan Melamed,N. Mottet,Gladell P. Paner,Hemamali Samaratunga,Ivo G. Schoots,Jeffry P. Simko,Toyonori Tsuzuki,Murali Varma,Anne Y. Warren,Thomas M. Wheeler,Sean R. Williamson,Kenneth A. Iczkowski +19 more